CVS Caremark disclosed more multibillion dollar contract losses in its pharmacy benefits management business and said the head of the unit will depart.

Drugstore operator and pharmacy benefits manager CVS Caremark Corp. is scheduled to report its third-quarter results Thursday morning. The following is a summary of key developments and analyst commentary for the period.

Stocks finished mixed Tuesday as techs struggled after a downgrade on Intel. Transports rose following news that that Warren Buffett is buying Burlington Northern railroad. Industrials also gained after this week's encouraging manufacturing reports.

Stocks tumbled Tuesday, led by techs after an analyst downgrade on Intel. Transports rose following news that Warren Buffett is buying Burlington Northern railroad.

What follows is a roundup of corporate earnings reports for Tuesday, Nov.3.

Medco Health Solutions Inc., the largest U.S. pharmacy benefits manager, said Tuesday its profit rose 13.5 percent as the company gained new clients and benefited from price inflation of brand-name drugs.

With the markets in volatility mode, investors will likely be focusing on the Federal Reserve Tuesday, even though the 2-day Federal Open Market Committee meeting that begins this afternoon won't conclude until Wednesday. 

Pharmacy benefits managers Medco Health Solutions Inc. and CVS Caremark Corp. said Monday they each received one-year contract extensions with drug benefit programs for federal employees.

Medco Health Solutions Inc., the largest U.S. pharmacy benefits manager, is scheduled to report its third-quarter results Tuesday morning. The following is a summary of key developments and analyst commentary for the period.

Stocks declined Wednesday as weak demand for today's Treasury auction and a sharp drop in oil prices dragged on the market. A disappointing durable-goods report didn't help either.

Stocks declined Wednesday after a report showed a much sharper drop in durable-goods orders than expected. Plus, a sharp selloff in China dragged on oil prices, which also weighed on the market.

Futures tumbled Wednesday after a report showed a much sharper drop in durable-goods orders than expected. Plus, a sharp selloff in China dragged on oil prices, which also weighed on the market.

Prescription drug use in the U.S. fell last year, although total spending on drugs increased as prices rose sharply on brand-name products.